CHRONO-MECHANISMS of CARDIOMETABOLIC PHARMACOLOGY
心脏代谢药理学的时间机制
基本信息
- 批准号:10271560
- 负责人:
- 金额:$ 39.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-21 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:ARNTL geneAblationAcuteAllelesAntidiabetic DrugsBindingBiological MarkersBranched-Chain Amino AcidsCardiacCardiac MyocytesCardiovascular DiseasesCatabolismChronicClinical TrialsCorticosteroneDataDepressed moodDiabetes MellitusDiabetic mouseDiseaseDoseGlucocorticoid ReceptorGlucocorticoidsGlucoseHalf-LifeHealthHeartHormonesImpairmentInjuryInsulin ResistanceIntakeKnock-inLinkLow Cardiac Output SyndromeMediatingMetabolicMetabolic acidosisMetabolic syndromeMetabolismMitochondriaModelingMolecularMusMuscleNuclear TranslocationNutrientObesityOrganPatientsPharmacologyPhasePrednisoneProdrugsPublishingReceptor ActivationRegimenRoleSteroidsStriated MusclesTestingTimeTransgenic MiceTransgenic Modelbasecardiometabolismcircadiancircadian pacemakercircadian regulationcombatdiabeticdiabetic cardiomyopathyepigenomicsflexibilityheart circulationheart functionheart metabolismimprovedinsulin sensitivitynovelnutrient metabolismoxidationprogramsreceptorreceptor sensitivityresponsetranscription factoruptakevirtual
项目摘要
PROJECT SUMMARY
Glucocorticoid steroids are conserved pleiotropic hormones regulating the circadian cycle of energy utilization
and storage in virtually all our organs. Nutrient metabolism in the heart is critical to adapt the high energy
demand to circadian oscillations and/or diseased states like diabetic cardiomyopathy. Glucocorticoids exert
their effects through the glucocorticoid receptor (GR), which is required for normal heart function. Indeed,
synthetic glucocorticoids are routinely used to rescue cardiac conditions of metabolic acidosis and depressed
function, such as low cardiac output syndrome. However, chronic GR over-stimulation with synthetic
glucocorticoids promotes metabolic syndrome and cardiovascular diseases. Thus, the molecular and circadian
effects of synthetic glucocorticoids and their receptor on cardiac metabolism are still unresolved. Using
dystrophic mice as model of chronic striated muscle injury, I discovered that intermittent dosing (once-weekly)
of glucocorticoids boosts nutrient utilization and insulin sensitivity in dystrophic muscle and heart. Here I
postulate that intermittent glucocorticoids improve cardiometabolic health beyond the dystrophic heart and can
be exploited to combat diabetic cardiomyopathy. In mice, oscillations of endogenous corticosterone and
circadian clock factors create a critical time window for acute GR responsiveness to pharmacological activation
in the early diurnal phase. Indeed, I found that diurnal – but not nocturnal – regimens of intermittent prednisone
improved cardiac function and metabolism in wildtype hearts. Diurnal administration was critical for the
prednisone-driven GR program to boost mitochondrial capacity and activate the metabolic regulators KLF15
and AMPK. Also, diurnal prednisone reduced 3-hydroxyisobutyrate (3-HIB), biomarker of impaired catabolism
of branched chain amino acids (BCAA) and insulin resistance in diabetes. Thus, I hypothesize that chrono-
pharmacology with diurnal glucocorticoids promotes cardiometabolic health through GR, KLF15 and AMPK
activation, and reduces 3-HIB as biomarker of metabolic rescue in diabetic cardiomyopathy. To test this
hypothesis, we will articulate the project to test three complementary mechanisms: in Aim 1, we will test the
requirement for GR and the clock factor BMAL in the effects of diurnal prednisone on mitochondrial capacity in
heart; in Aim 2, we will define requirement and epigenomic mechanisms for the GR-activated KLF15 in
reshaping nutrient utilization in cardiomyocytes in response to prednisone chrono-dosing; in Aim 3, we will
determine the role of AMPK and BCAA oxidation in mediating the effects of diurnal intermittent prednisone on
metabolic flexibility and 3-HIB levels in diabetic cardiomyopathy. This proposal charts a novel path to
cardiometabolic rescue by exploiting the circadian-gated response to synthetic glucocorticoids in heart.
Defining unprecedented mechanisms of interplay between glucocorticoid cascades and circadian clock, the
project will provide evidence for time-restricted intermittent dosing as “flip switch” of glucocorticoid action in
heart metabolism, converting these drugs from “pro-diabetic” to “anti-diabetic” in cardiometabolic health.
项目总结
糖皮质激素是一种保守的多效性激素,调节能量利用的昼夜周期。
并储存在我们几乎所有的器官中。心脏中的营养代谢是适应高能量的关键
对昼夜节律振荡和/或糖尿病心肌病等疾病状态的需求。糖皮质激素强效
它们通过糖皮质激素受体(GR)发挥作用,而GR是正常心脏功能所必需的。的确,
人工合成的糖皮质激素常用于抢救代谢性酸中毒和抑郁的心脏疾病
功能障碍,如低心排血量综合征。然而,慢性GR过度刺激与合成
糖皮质激素促进代谢综合征和心血管疾病。因此,分子和昼夜节律
人工合成的糖皮质激素及其受体对心脏代谢的影响仍未解决。vbl.使用
以营养不良小鼠为慢性横纹肌损伤模型,发现间歇给药(每周一次)
糖皮质激素可提高营养不良肌肉和心脏的营养利用和胰岛素敏感性。在这里,我
假设间歇性糖皮质激素改善了营养不良心脏以外的心脏代谢健康,并可以
被用来对抗糖尿病心肌病。在小鼠中,内源性皮质酮和皮质酮的振荡
生物钟因素为急性GR对药物激活的反应创造了一个关键的时间窗口
在白天的早期阶段。事实上,我发现间歇性强的松的白天疗法--但不是夜间疗法
改善野生型心脏的心功能和代谢。昼夜给药是关键的
强的松驱动的GR程序提高线粒体能力并激活代谢调节因子KLF15
和AMPK。此外,昼夜泼尼松降低了3-羟基异丁酸(3-HIB),这是分解代谢受损的生物标志物
支链氨基酸(BCAA)与糖尿病胰岛素抵抗的关系。因此,我假设计时器-
糖皮质激素通过GR、KLF15和AMPK促进心脏代谢健康
活化,降低3-HIB作为糖尿病心肌病代谢挽救的生物标志物。为了测试这一点
假设,我们将阐明该项目以测试三个互补的机制:在目标1中,我们将测试
昼夜泼尼松对线粒体能力影响中对GR和时钟因子BMAL的需求
在目标2中,我们将定义GR激活的KLF15的需求和表观基因组机制
在目标3中,我们将重塑心肌细胞中营养物质的利用以响应泼尼松的计时剂量
确定AMPK和BCAA氧化在调节昼夜间歇强的松作用中的作用
糖尿病心肌病的代谢灵活性和3-HIB水平。这项提议描绘了一条新的道路,
利用心脏对合成糖皮质激素的昼夜门控反应进行心脏新陈代谢抢救。
定义了糖皮质激素级联反应和生物钟之间前所未有的相互作用机制,
该项目将提供证据,证明有时间限制的间歇给药是糖皮质激素作用的“触发开关”
心脏代谢,使这些药物在心脏代谢健康中从“促糖尿病”转变为“抗糖尿病”。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mattia Quattrocelli其他文献
Mattia Quattrocelli的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mattia Quattrocelli', 18)}}的其他基金
Harnessing novel glucocorticoid biology to treat diabetic cardiomyopathy
利用新型糖皮质激素生物学治疗糖尿病心肌病
- 批准号:
10733533 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
ROLE OF CIRCADIAN RHYTHM AND INTERMITTENT DOSING IN MUSCLE TRIGLYCERIDE LIPASE INDUCTION BY GLUCOCORTICOIDS
昼夜节律和间歇给药在糖皮质激素诱导肌肉甘油三酯脂肪酶中的作用
- 批准号:
10657826 - 财政年份:2022
- 资助金额:
$ 39.75万 - 项目类别:
ROLE OF CIRCADIAN RHYTHM AND INTERMITTENT DOSING IN MUSCLE TRIGLYCERIDE LIPASE INDUCTION BY GLUCOCORTICOIDS
昼夜节律和间歇给药在糖皮质激素诱导肌肉甘油三酯脂肪酶中的作用
- 批准号:
10518578 - 财政年份:2022
- 资助金额:
$ 39.75万 - 项目类别:
Coordinated mechanisms to rescue bioenergetics and sarcopenia in aging
拯救衰老过程中生物能学和肌肉减少症的协调机制
- 批准号:
10672292 - 财政年份:2022
- 资助金额:
$ 39.75万 - 项目类别:
Glucocorticoid and circadian clock coregulation of insulin sensitivity and metabolism
糖皮质激素和生物钟共同调节胰岛素敏感性和代谢
- 批准号:
10191173 - 财政年份:2019
- 资助金额:
$ 39.75万 - 项目类别:
Glucocorticoid and circadian clock coregulation of insulin sensitivity and metabolism
糖皮质激素和生物钟共同调节胰岛素敏感性和代谢
- 批准号:
10166838 - 财政年份:2019
- 资助金额:
$ 39.75万 - 项目类别:
Glucocorticoid and circadian clock coregulation of insulin sensitivity and metabolism
糖皮质激素和生物钟共同调节胰岛素敏感性和代谢
- 批准号:
9806667 - 财政年份:2019
- 资助金额:
$ 39.75万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 39.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
- 批准号:
24K11201 - 财政年份:2024
- 资助金额:
$ 39.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
- 批准号:
24K11281 - 财政年份:2024
- 资助金额:
$ 39.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
- 批准号:
EP/Z001145/1 - 财政年份:2024
- 资助金额:
$ 39.75万 - 项目类别:
Fellowship
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
- 批准号:
2338890 - 财政年份:2024
- 资助金额:
$ 39.75万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334777 - 财政年份:2024
- 资助金额:
$ 39.75万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334775 - 财政年份:2024
- 资助金额:
$ 39.75万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334776 - 财政年份:2024
- 资助金额:
$ 39.75万 - 项目类别:
Continuing Grant
Cryo laser-ablation system (157+193nm) with 'triple-quad' plasma mass spectrometer, Cryo-LA-ICPMS/MS
带有“三重四极杆”等离子体质谱仪、Cryo-LA-ICPMS/MS 的冷冻激光烧蚀系统 (157 193nm)
- 批准号:
515081333 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
Major Research Instrumentation
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
- 批准号:
2320040 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
Standard Grant














{{item.name}}会员




